Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 1726-1736

  Quinn, Michael ^a   Turula, Holly ^a,b   Tandon, Mayank ^a,c   Deslouches, Berthony ^a,d   Moghbeli, Toktam ^a   Snyder, Christopher M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PHENOTYPE; UPREGULATION; VIRUS LATENCY; VIRUS STRAIN; ADOPTIVE IMMUNOTHERAPY; ANIMAL; DISEASE MODEL; DNA MICROARRAY; HERPES VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MUROMEGALOVIRUS; PROCEDURES; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, TRANSGENIC; MUROMEGALOVIRUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTE SUBSETS;

EID: 84922569806     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402757     Document Type: Article

References (75)

1. Staras, S. A., S. C. Dollard, K. W. Radford, W. D. Flanders, R. F. Pass, and M. J. Cannon. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin. Infect. Dis. 43: 1143-1151.
2. Polić, B., H. Hengel, A. Krmpotić, J. Trgovcich, I. Pavić, P. Luccaronin, S. Jonjić, and U. H. Koszinowski. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188: 1047-1054.
3. Simon, C. O., R. Holtappels, H.-M. Tervo, V. Böhm, T. Däubner, S. A. Oehrlein-Karpi, B. Kühnapfel, A. Renzaho, D. Strand, J. Podlech, et al. 2006. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 80: 10436-10456.
4. Holtappels, R., V. Böhm, J. Podlech, and M. J. Reddehase. 2008. CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Med. Microbiol. Immunol. (Berl.) 197: 125-134.
5. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044.
6. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
7. Barron, M. A., D. Gao, K. L. Springer, J. A. Patterson, M. W. Brunvand, P. A. McSweeney, C. Zeng, A. E. Barón, and A. Weinberg. 2009. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 49: 1777-1783.
8. Feuchtinger, T., K. Opherk, W. A. Bethge, M. S. Topp, F. R. Schuster, E. M. Weissinger, M. Mohty, R. Or, M. Maschan, M. Schumm, et al. 2010. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 116: 4360-4367.
9. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78: 1373-1380.
10. Li, C. R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83: 1971-1979.
11. Gratama, J. W., M. Boeckh, R. Nakamura, J. J. Cornelissen, R. A. Brooimans, J. A. Zaia, S. J. Forman, K. Gaal, K. R. Bray, G. H. Gasior, et al. 2010. Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study. Blood 116: 1655-1662.
12. Boeckh, M., W. Leisenring, S. R. Riddell, R. A. Bowden, M. L. Huang, D. Myerson, T. Stevens-Ayers, M. E. Flowers, T. Cunningham, and L. Corey. 2003. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101: 407-414.
13. Peggs, K. S., S. Verfuerth, A. Pizzey, S. L. Chow, K. Thomson, and S. Mackinnon. 2009. Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation. Clin. Infect. Dis. 49: 1851-1860.
14. Peggs, K. S., K. Thomson, E. Samuel, G. Dyer, J. Armoogum, R. Chakraverty, K. Pang, S. Mackinnon, and M. W. Lowdell. 2011. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin. Infect. Dis. 52: 49-57.
15. Schmitt, A., T. Tonn, D. H. Busch, G. U. Grigoleit, H. Einsele, M. Odendahl, L. Germeroth, M. Ringhoffer, S. Ringhoffer, M. Wiesneth, et al. 2011. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 51: 591-599.
16. Blyth, E., L. Clancy, R. Simms, C. K. K. Ma, J. Burgess, S. Deo, K. Byth, M.-C. Dubosq, P. J. Shaw, K. P. Micklethwaite, and D. J. Gottlieb. 2013. Donor-derived CMV-specific T cells reduce the requirement for CMV-directed phar-macotherapy after allogeneic stem cell transplantation. Blood 121: 3745-3758.
17. Cobbold, M., N. Khan, B. Pourgheysari, S. Tauro, D. McDonald, H. Osman, M. Assenmacher, L. Billingham, C. Steward, C. Crawley, et al. 2005. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202: 379-386.
18. Papadopoulou, A., U. Gerdemann, U. L. Katari, I. Tzannou, H. Liu, C. Martinez, K. Leung, G. Carrum, A. P. Gee, J. F. Vera, et al. 2014. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci. Transl. Med. 6: 242ra283.
19. Holtappels, R., M. F. Pahl-Seibert, D. Thomas, and M. J. Reddehase. 2000. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cyto-megalovirus infection of the lungs. J. Virol. 74: 11495-11503.
20. Holtappels, R., D. Thomas, J. Podlech, and M. J. Reddehase. 2002. Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J. Virol. 76: 151-164.
21. Karrer, U., S. Sierro, M. Wagner, A. Oxenius, H. Hengel, U. H. Koszinowski, R. E. Phillips, and P. Klenerman. 2003. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 170: 2022-2029.
22. Ouyang, Q., W. M. Wagner, D. Voehringer, A. Wikby, T. Klatt, S. Walter, C. A. Müller, H. Pircher, and G. Pawelec. 2003. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38: 911-920.
23. Sierro, S., R. Rothkopf, and P. Klenerman. 2005. Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur. J. Immunol. 35: 1113-1123.
24. Sylwester, A. W., B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
25. Munks, M. W., K. S. Cho, A. K. Pinto, S. Sierro, P. Klenerman, and A. B. Hill. 2006. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J. Immunol. 177: 450-458.
26. Komatsu, H., A. Inui, T. Sogo, T. Fujisawa, H. Nagasaka, S. Nonoyama, S. Sierro, J. Northfield, M. Lucas, A. Vargas, and P. Klenerman. 2006. Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses. Immun. Ageing 3: 11.
27. Snyder, C. M., K. S. Cho, E. L. Bonnett, S. van Dommelen, G. R. Shellam, and A. B. Hill. 2008. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29: 650-659.
28. Smith, C. J., H. Turula, and C. M. Snyder. 2014. Systemic hematogenous maintenance of memory inflation by MCMV infection. PLoS Pathog. 10: e1004233.
29. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
30. van Leeuwen, E. M., L. E. Gamadia, P. A. Baars, E. B. Remmerswaal, I. J. ten Berge, and R. A. van Lier. 2002. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J. Immunol. 169: 5838-5843.
31. Gamadia, L. E., E. M. van Leeuwen, E. B. Remmerswaal, S. L. Yong, S. Surachno, P. M. Wertheim-van Dillen, I. J. Ten Berge, and R. A. Van Lier. 2004. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 172: 6107-6114.
32. van Leeuwen, E. M., G. J. de Bree, E. B. Remmerswaal, S. L. Yong, K. Tesselaar, I. J. ten Berge, and R. A. van Lier. 2005. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 106: 2091-2098.
33. Waller, E. C., N. McKinney, R. Hicks, A. J. Carmichael, J. G. Sissons, and M. R. Wills. 2007. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA (HI)) CD8(+) T cells. Blood 110: 4360-4366.
34. Wallace, D. L., J. E. Masters, C. M. De Lara, S. M. Henson, A. Worth, Y. Zhang, S. R. Kumar, P. C. Beverley, A. N. Akbar, and D. C. Macallan. 2011. Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology 132: 27-38.
35. Rufer, N., A. Zippelius, P. Batard, M. J. Pittet, I. Kurth, P. Corthesy, J. C. Cerottini, S. Leyvraz, E. Roosnek, M. Nabholz, and P. Romero. 2003. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 102: 1779-1787.
36. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
37. Iancu, E. M., P. Corthesy, P. Baumgaertner, E. Devevre, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer. 2009. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J. Immunol. 183: 319-331.
38. Gattinoni, L., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290-1297.
39. Graef, P., V. R. Buchholz, C. Stemberger, M. Flossdorf, L. Henkel, M. Schiemann, I. Drexler, T. Höfer, S. R. Riddell, and D. H. Busch. 2014. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. Immunity 41: 116-126.
40. Berger, C., M. C. Jensen, P. M. Lansdorp, M. Gough, C. Elliott, and S. R. Riddell. 2008. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118: 294-305.
41. Scheinberg, P., J. J. Melenhorst, J. M. Brenchley, B. J. Hill, N. F. Hensel, P. K. Chattopadhyay, M. Roederer, L. J. Picker, D. A. Price, A. J. Barrett, and D. C. Douek. 2009. The transfer of adaptive immunity to CMV during hema-topoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. Blood 114: 5071-5080.
42. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73: 7056-7060.
43. Snyder, C. M., K. S. Cho, E. L. Bonnett, J. E. Allan, and A. B. Hill. 2011. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog. 7: e1002295.
44. Farrington, L. A., T. A. Smith, F. Grey, A. B. Hill, and C. M. Snyder. 2013. Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection. J. Immunol. 190: 3410-3416.
45. Turula, H., C. J. Smith, F. Grey, K. A. Zurbach, and C. M. Snyder. 2013. Competition between T cells maintains clonal dominance during memory inflation induced by MCMV. Eur. J. Immunol. 43: 1252-1263.
46. Welten, S. P. M., A. Redeker, K. L. Franken, C. A. Benedict, H. Yagita, F. M. Wensveen, J. Borst, C. J. M. Melief, R. A. W. van Lier, K. P. J. M. van Gisbergen, and R. Arens. 2013. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J. Virol. 87: 6851-6865.
47. Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5: R80.
48. Carvalho, B. S., and R. A. Irizarry. 2010. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26: 2363-2367.
49. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
50. MacDonald, J. W. Mogene10Sttranscriptcluster.db: Affymetrix mogene10 annotation data (chip mogene10sttranscriptcluster). R package version 8.1.0. Available at: www.bioconductor.org/packages/release/data/annotation/html/mogene10sttranscriptcluster.db.html. Accessed: October 2013.
51. Smyth, G. K. 2005. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer, New York, p. 397-420.
52. Smyth, G. K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3: Article 3.
53. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210.
54. Hertoghs, K. M. L., P. D. Moerland, A. van Stijn, E. B. M. Remmerswaal, S. L. Yong, P. J. E. J. van de Berg, S. M. van Ham, F. Baas, I. J. M. ten Berge, and R. A. W. van Lier. 2010. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J. Clin. Invest. 120: 4077-4090.
55. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550.
56. Thimme, R., V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79: 12112-12116.
57. Hutchinson, S., S. Sims, G. O'Hara, J. Silk, U. Gileadi, V. Cerundolo, and P. Klenerman. 2011. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 6: e14646.
58. Kern, F., E. Khatamzas, I. Surel, C. Frömmel, P. Reinke, S. L. Waldrop, L. J. Picker, and H. D. Volk. 1999. Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur. J. Immunol. 29: 2908-2915.
59. Tomiyama, H., H. Takata, T. Matsuda, and M. Takiguchi. 2004. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur. J. Immunol. 34: 999-1010.
60. Jabbari, A., and J. T. Harty. 2006. Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. J. Exp. Med. 203: 919-932.
61. Masopust, D., S. J. Ha, V. Vezys, and R. Ahmed. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177: 831-839.
62. Wirth, T. C., H. H. Xue, D. Rai, J. T. Sabel, T. Bair, J. T. Harty, and V. P. Badovinac. 2010. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33: 128-140.
63. Fraser, K. A., J. M. Schenkel, S. C. Jameson, V. Vezys, and D. Masopust. 2013. Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting. Immunity 39: 171-183.
64. Kumar, D., S. Chernenko, G. Moussa, I. Cobos, O. Manuel, J. Preiksaitis, S. Venkataraman, and A. Humar. 2009. Cell-mediated immunity to predict cy-tomegalovirus disease in high-risk solid organ transplant recipients. Am. J. Transplant. 9: 1214-1222.
65. Harvala, H., C. Stewart, K. Muller, S. Burns, L. Marson, A. MacGilchrist, and I. Johannessen. 2013. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy. J. Med. Virol. 85: 893-898.
66. Manuel, O., S. Husain, D. Kumar, C. Zayas, S. Mawhorter, M. E. Levi, J. Kalpoe, L. Lisboa, L. Ely, D. R. Kaul, et al. 2013. Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cyto-megalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin. Infect. Dis. 56: 817-824.
67. Ljungman, P., M. Hakki, and M. Boeckh. 2011. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol. Oncol. Clin. North Am. 25: 151-169.
68. Jonjić, S., I. Pavić, B. Polić, I. Crnković, P. Lucin, and U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179: 1713-1717.
69. Cush, S. S., and E. Flaño. 2011. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during γ-herpesvirus infection. J. Immunol. 186: 4051-4058.
70. Appay, V., R. A. W. van Lier, F. Sallusto, and M. Roederer. 2008. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
71. Ciocca, M. L., B. E. Barnett, J. K. Burkhardt, J. T. Chang, and S. L. Reiner. 2012. Cutting edge: asymmetric memory T cell division in response to rechallenge. J. Immunol. 188: 4145-4148.
72. Kurz, S. K., M. Rapp, H. P. Steffens, N. K. Grzimek, S. Schmalz, and M. J. Reddehase. 1999. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73: 482-494.
73. Kurz, S. K., and M. J. Reddehase. 1999. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J. Virol. 73: 8612-8622.
74. Snyder, C. M. 2011. Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8(+) T cells during cytomegalovirus infection. Immunol. Res. 51: 195-204.
75. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.